Pfizer makes another ThermaCare recall

26 April 2019 - Deborah Wilkes

Pfizer Consumer Healthcare has voluntarily recalled one lot of ThermaCare HeatWraps Back Pain Therapy at the consumer level in the US. It is the second recall for ThermaCare HeatWraps in six months.

The recall was initiated because the HeatWraps could potentially include "cells that have a higher cell temperature than specified".

Pfizer said this posed a "potential risk of skin injuries such as burns/blisters and/or skin irritation on the wrap applied area".

In November 2018, Pfizer Consumer Healthcare voluntarily recalled six lots of ThermaCare HeatWraps at the consumer level in the US (click here to read the News story).

The company said at the time that products from the six lots had "a potential to leak ingredients that are contained in the heat cell wrap". "The use of a leaking/damaged heat cell wrap could cause skin injuries such as burns/blisters and/or skin irritation on the wrap applied area," commented the company.

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE

Click tags below for more information on topics:

Pfizer

Back to Industry News

Share this page: